Replies to post #157081 on Biotech Values

[mcbio]

Golly... what a surprise! -g- (Actually the only surprise is that they now say they will have data by ASCO - which is earlier than they had previously stated.)

Will be interesting to see the full data and if they do intend to push forward into an additional P2 CRC trial, based on the biomarker data.

Of perhaps more importance to me is the reference to possibly having the P3 HCC data by late 2014; that seems to me to be an earlier timeline than prior guidance. It wasn't clear to me if the CEO was referring to final data or some kind of interim look, though.

[BTH]

Pualo Pucci's interesting data:

They found it worked extremely well in patients who had medium levels of c-Met, who were right handed, drove a Toyota, caucasian with blue green eyes, and were between 150-170 lbs.

ARQL